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The relationship between drugs and ulceration of the gastrointestinal (GI) tract remains a matter for debate (Langman & Cooke 1976) . To all clinicians, the incidence of patients with a GI haemorrhage who have just taken an analgesic drug points to a causal association. However, so widespread is the taking of analgesics-for example, in 1976 nearly 3500million aspirin tablets were sold in Britain (Fryers 1977 ) -that an association has been difficult to prove. This paper briefly reviews the evidence for a causal relationship between drugs and ulcers, particularly looking at complications of ulceration.
Oesophageal ulceration A number of case reports point to certain drugs causing oesophageal ulceration. Potassiumcontaining tablets seem particularly liable to cause ulceration. Tetracycline and emepronium bromide (Cetiprin) have also been implicated. The cause seems to be delay in the tablet clearing the oesophagus (Evans & Roberts 1976) , with more than half the subjects retaining tablets there for more than five minutes. In patients with abnormal motility or a hiatus hernia, the tablet may stick in the lower gullet for much longer.
Gastric and duodenal ulceration The overwhelming evidence from Australian studies is that aspirin ingestion increases the incidence of chronic gastric ulceration (GU), especially in women (Piper et al. 1977) . The finding that analgesic intake was high in patients whose chronic ulcer was in remission suggests that pain from the ulcer itself was not the cause of the analgesic ingestion.
Much less is known about the effects of analgesics upon duodenal ulceration (DU). There is no evidence that duodenal ulcers are more frequent in analgesic takers than in a control population (Langman & Cooke 1976 ).
Complications of ulceration
Haemorrhage andaspirin Acetylsalicylic acid (ASA) can damage the gastric mucosal integrity by causing increased permeability of the mucosal barrier, a reduction in the potential differenceof the mucosa, and an inflammatory reaction. It causes an increase in microscopic blood loss from the gut, from ' a control 1-2 ml/day to 3-6 ml/day. Furthermore, ASA causes capillary fragility, increased fibrinolysis and a prolonged bleeding time. From this it would seem certain that ASA is responsible for an increased incidence of massive GI bleeding, but the evidence is not convincing.
Reviews of the literature have pointed out the inadequacy of the data (Langman 1970 , Shirley 1977 . Difficulty with a controlgroup is a major problem. One other problem which has not been examined is that most of the studies were done before endoscopy became available. The endoscope has made an impressive change in our diagnostic accuracy, especially for mucosal lesions, often enabling us to detect the exact site of bleeding (Foster et al. 1978) . A recent study (Graham & Davies 1978) investigated the relationship between ASA and GI bleeding in 289 patients, 90% of whom were diagnosed by endoscopy. They found no relationship for ASA -nor for alcohol. On the other hand, in a most detailed study from the Boston collaborative drug surveillance programme, Levy (1974) between the heavy use of ASA (ASA at least 4 days/week for over three months) and GI bleeding. When patients with known ulcers were investigated as a sub-group, only GU and ASA were associated with bleeding, and not DU and ASA.
Haemorrhage and steroids
The review of Conn & Blitzer (1976) embraced 26 double-blind controlled trials and 16 non double-blind studies, where steroids had been used, amassing 5331 cases from the literature. Their conclusions were that steroids were associated with haemorrhage where prolonged treatment, high total dose, and previous ulceration were found. The relationship was not strong, however.
Haemorrhage and non-steroid antirheumatic (NSAR) drugs
Although microscopic blood loss has been found with most NSAR drugs, their ability to cause massive bleeding has not been fully investigated. Preliminary studies at Nottingham (Langman 1977) showed an increased incidence of bleeding with aspirin and, surprisingly, paracetamol, but more particularly with NSAR drugs. Further studies are needed.
Perforation . In a retrospective study of 195 patients who perforated, 18% were taking anti-inflammatory drugs (Jorgensen 1977) . A smaller prospective study supported an association, notably for prepyloric ulcers.
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Conclusion
Evidence from the literature supports the view that acetylsalicylic acid causes gastric ulceration and that prolonged heavy ingestion may increase the risk of massive GI bleeding. Haemorrhage in steroid takers is also related to duration of therapy and dose. Perforation is probably more common in anti-inflammatory drug takers.
The association between complications of peptic ulcers and analgesic taking is not as strong as general belief would suggest. Management of patients who are on anti-inflammatory drugs and have a complication should be along conventional lines. For haemorrhage it is essential to investigate as usual-discounting any positive or negative history of analgesic taking. Cimetidine, an H 2 receptor antagonist, is useful for the treatment of bleeding erosions, but appears to be of little value in bleeding peptic ulcers (La Brooy et al. 1978) .
